CNM Publications 2009 to Present

Found 95 results
Author Title Type [ Year(Asc)]
Haspel N, Zanuy D, Nussinov R, Teesalu T, Ruoslahti E, Alemán C.  2011.  Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach.. Biochemistry. 50(10):1755-62.
Kinsella JM, Ananda S, Andrew JS, Grondek JF, Chien M-P, Scadeng M, Gianneschi NC, Ruoslahti E, Sailor MJ.  2011.  Enhanced magnetic resonance contrast of Fe₃O₄ nanoparticles trapped in a porous silicon nanoparticle host.. Adv Mater. 23(36):H248-53.
Ismail MNazri, Stone EL, Panico M, Lee SHo, Luu Y, Ramirez K, Ho SB, Fukuda M, Marth JD, Haslam SM et al..  2011.  High-sensitivity O-glycomic analysis of mice deficient in core 2 {beta}1,6-N-acetylglucosaminyltransferases.. Glycobiology. 21(1):82-98.
Fraikin J-L, Teesalu T, McKenney CM, Ruoslahti E, Cleland AN.  2011.  A high-throughput label-free nanoparticle analyser.. Nat Nanotechnol. 6(5):308-13.
Karmali PPrakash, Brunquell C, Tram H, Ireland SKale, Ruoslahti E, Biliran H.  2011.  Metastasis of tumor cells is enhanced by downregulation of Bit1.. PLoS One. 6(8):e23840.
Sánchez-Martín D, Cuesta AM, Fogal V, Ruoslahti E, Álvarez-Vallina L.  2011.  The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategies.. J Biol Chem. 286(7):5197-203.
von Maltzahn G, Park J-H, Lin KY, Singh N, Schwöppe C, Mesters R, Berdel WE, Ruoslahti E, Sailor MJ, Bhatia SN.  2011.  Nanoparticles that communicate in vivo to amplify tumour targeting.. Nat Mater. 10(7):545-52.
Ohtsubo K, Chen MZ, Olefsky JM, Marth JD.  2011.  Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.. Nat Med. 17(9):1067-75.
Urakami T, Järvinen TAH, Toba M, Sawada J, Ambalavanan N, Mann D, McMurtry I, Oka M, Ruoslahti E, Komatsu M.  2011.  Peptide-directed highly selective targeting of pulmonary arterial hypertension.. Am J Pathol. 178(6):2489-95.
Yang Y-H, Rajaiah R, Ruoslahti E, Moudgil KD.  2011.  Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis.. Proc Natl Acad Sci U S A. 108(31):12857-62.
Wang J, Liu Y, Teesalu T, Sugahara KN, Kotamrajua VRamana, Adams JD, Ferguson BS, Gong Q, Oh SSoo, Csordas AT et al..  2011.  Selection of phage-displayed peptides on live adherent cells in microfluidic channels.. Proc Natl Acad Sci U S A. 108(17):6909-14.
Hamzah J, Kotamraju VR, Seo JW, Agemy L, Fogal V, Mahakian LM, Peters D, Roth L, M Gagnon KJ, Ferrara KW et al..  2011.  Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice.. Proc Natl Acad Sci U S A. 108(17):7154-9.
Agemy L, Friedmann-Morvinski D, Kotamraju VRamana, Roth L, Sugahara KN, Girard OM, Mattrey RF, Verma IM, Ruoslahti E.  2011.  Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma.. Proc Natl Acad Sci U S A. 108(42):17450-5.
Kinsella JM, Jimenez RE, Karmali PP, Rush AM, V Kotamraju R, Gianneschi NC, Ruoslahti E, Stupack D, Sailor MJ.  2011.  X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles.. Angew Chem Int Ed Engl. 50(51):12308-11.
Kitazume S, Imamaki R, Ogawa K, Komi Y, Futakawa S, Kojima S, Hashimoto Y, Marth JD, Paulson JC, Taniguchi N.  2010.  Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling.. J Biol Chem. 285(9):6515-21.
Sugahara KN, Teesalu T, Karmali PPrakash, Kotamraju VRamana, Agemy L, Greenwald DR, Ruoslahti E.  2010.  Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.. Science. 328(5981):1031-5.
Park J-H, von Maltzahn G, Xu MJue, Fogal V, Kotamraju VRamana, Ruoslahti E, Bhatia SN, Sailor MJ.  2010.  Cooperative nanomaterial system to sensitize, target, and treat tumors.. Proc Natl Acad Sci U S A. 107(3):981-6.
Park J-H, von Maltzahn G, Ong LL, Centrone A, T Hatton A, Ruoslahti E, Bhatia SN, Sailor MJ.  2010.  Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery.. Adv Mater. 22(8):880-5.
Lee SHo, Yu S-Y, Nakayama J, Khoo K-H, Stone EL, Fukuda MN, Marth JD, Fukuda M.  2010.  Core2 O-glycan structure is essential for the cell surface expression of sucrase isomaltase and dipeptidyl peptidase-IV during intestinal cell differentiation.. J Biol Chem. 285(48):37683-92.
Gu L, Park J-H, Duong KH, Ruoslahti E, Sailor MJ.  2010.  Magnetic luminescent porous silicon microparticles for localized delivery of molecular drug payloads.. Small. 6(22):2546-52.
Fogal V, Richardson AD, Karmali PP, Scheffler IE, Smith JW, Ruoslahti E.  2010.  Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation.. Mol Cell Biol. 30(6):1303-18.
Agemy L, Sugahara KN, Kotamraju VRamana, Gujraty K, Girard OM, Kono Y, Mattrey RF, Park J-H, Sailor MJ, Jiménez AI et al..  2010.  Nanoparticle-induced vascular blockade in human prostate cancer.. Blood. 116(15):2847-56.
Takamatsu S, Antonopoulos A, Ohtsubo K, Ditto D, Chiba Y, Le DT, Morris HR, Haslam SM, Dell A, Marth JD et al..  2010.  Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice.. Glycobiology. 20(4):485-97.
Malik G, Knowles LM, Dhir, iv R, Xu S, Yang S, Ruoslahti E, Pilch J.  2010.  Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion.. Cancer Res. 70(11):4327-34.
Kolhar P, Kotamraju VRamana, Hikita ST, Clegg DO, Ruoslahti E.  2010.  Synthetic surfaces for human embryonic stem cell culture.. J Biotechnol. 146(3):143-6.